Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen + Jaeumkanghwa-tang Extract Effects on Endometrium in Breast Cancer Patients (Pilot Study)
KCT0002030Phase 4Recruiting
- Sponsor
- Comprehensive & Integrative Medicine Institute
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tamoxifen in breast cancer, sponsored by Comprehensive & Integrative Medicine Institute. Started Mar 2016; status: recruiting.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0002030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002030.